|
Q1 FY2019
As of Sep 29, 2018
|
Q4 FY2018
As of Jun 30, 2018
|
Q3 FY2018
As of Mar 31, 2018
|
Q2 FY2018
As of Dec 30, 2017
|
Q1 FY2018
As of Sep 30, 2017
|
Q4 FY2017
As of Jul 1, 2017
|
Q3 FY2017
As of Apr 1, 2017
|
Q2 FY2017
As of Dec 31, 2016
|
Q1 FY2017
As of Oct 1, 2016
|
Q4 FY2016
As of Jul 2, 2016
|
Q3 FY2016
As of Mar 26, 2016
|
Q2 FY2016
As of Dec 26, 2015
|
Q1 FY2016
As of Sep 26, 2015
|
Q4 FY2015
As of Jun 27, 2015
|
Q3 FY2015
As of Mar 28, 2015
|
Q2 FY2015
As of Dec 27, 2014
|
Q1 FY2015
As of Sep 27, 2014
|
Q4 FY2014
As of Jun 28, 2014
|
Q3 FY2014
As of Mar 29, 2014
|
Q2 FY2014
As of Dec 28, 2013
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Short-term investments | ||||||||||||||||||||
| Accounts receivable, net of allowances for doubtful accounts of $1,458 and $1,393 as of September 29, 2018 and June 30, 2018, respectively | ||||||||||||||||||||
| Inventories | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Other intangible assets, net | ||||||||||||||||||||
| Deferred tax assets | ||||||||||||||||||||
| Other non-current assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued expenses and other liabilities | ||||||||||||||||||||
| Capital lease obligations, current | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Deferred gain on sale-leaseback | ||||||||||||||||||||
| Convertible notes payable | ||||||||||||||||||||
| Capital lease obligations, non-current | ||||||||||||||||||||
| Other non-current liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders’ equity: | ||||||||||||||||||||
| Preferred stock: 1,000 shares authorized; none issued and outstanding | ||||||||||||||||||||
| Common stock: $0.01 par value per share; 275,000 shares authorized; 171,601 shares issued and outstanding at September 29, 2018 and 170,675 shares issued and outstanding at June 30, 2018 | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated other comprehensive income | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Total liabilities and stockholders’ equity | ||||||||||||||||||||
Loading...
